Renaissance Technologies - FINCH THERAPEUTICS GROUP INC ownership

FINCH THERAPEUTICS GROUP INC's ticker is FNCH and the CUSIP is 31773D101. A total of 44 filers reported holding FINCH THERAPEUTICS GROUP INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of FINCH THERAPEUTICS GROUP INC
ValueSharesWeighting
Q1 2023$37
-37.3%
93,000
-24.3%
0.00%
Q4 2022$59
-99.9%
122,900
+202.7%
0.00%
Q3 2022$68,000
-38.2%
40,600
+4.9%
0.00%
Q2 2022$110,000
-51.3%
38,700
-14.0%
0.00%
Q1 2022$226,000
-39.9%
45,000
+19.4%
0.00%
Q4 2021$376,00037,6860.00%
Other shareholders
FINCH THERAPEUTICS GROUP INC shareholders Q3 2022
NameSharesValueWeighting ↓
Avenir Management Company, LLC 1,663,366$653,7033.23%
Bleichroeder LP 810,416$318,4930.07%
Ikarian Capital, LLC 237,553$93,3590.02%
LAKE STREET ADVISORS GROUP, LLC 739,136$2910.02%
Baupost Group 2,019,008$7930.01%
Proficio Capital Partners LLC 110,559$43,4500.01%
MSD Partners, L.P. 153,397$60,2850.01%
Ballentine Partners, LLC 143,603$56,4360.00%
SVB WEALTH LLC 253,054$99,4500.00%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 18,783$7,3820.00%
View complete list of FINCH THERAPEUTICS GROUP INC shareholders